BEAM:NASDAQ, Beam Therapeutics Inc.

BEAM stock overview

Beam Therapeutics Inc. (BEAM:NASDAQ) closed at $20.90 on November 20, 2026, down 0.19% on the day. The stock trades 45.4% below its 52-week high of $38.26 and 2.5% above its 52-week low of $20.39. Over the past year, it lost 5.9%. Beam Therapeutics Inc. is part of the Health Care sector.

Key figures

Price
$20.90
Day change
-0.19%
Volume
3,882,474
Average volume
2,022,326
Market cap
2B+
52-week range
$20.39 – $38.26
50-day average
$24.70
200-day average
$27.74

Price action over the past year

In 252 trading sessions since November 20, 2025, BEAM closed higher on 119 days (47%). Its best day was January 12, 2026 (+22.29%) and its worst was June 5, 2026 (-10.48%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

BEAM news

About Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises of Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Similar stocks

Find more stocks like BEAM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.